Company’s melanoma cancer vaccine being developed with Merck
Similar stories
6 outlets
See how this story developed, hour by hour
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
arstechnica.com
19.08.2026
Moderna's share price nearly doubles on hopes of cancer treatment breakthrough
news.sky.com
19.08.2026
Moderna Soars as Vaccine-Drug Combo Slows Recurrence of Melanoma
finance.yahoo.com
20.08.2026
mRNA Vaccine Stocks Rise on Moderna-Merck Success
wsj.com
19.08.2026
Moderna Cancer Trial Success Is a Shot in the Arm for Trump
newsweek.com
19.08.2026
Moderna’s stock doubles on promising cancer-vaccine results
marketwatch.com
19.08.2026
Related stories
Nvidia sales more than double to $96bn on bumper AI demand
Salesforce’s stock surges as AI momentum fuels revenue growth
I just had my first baby and don’t want to go back to work. Is quitting for a year a bad idea?
OpenAI says it took a week to detect its AI models had hacked Hugging Face
Why is Russia deliberately weakening its currency?
NVIDIA Corporation (NVDA) & Blackstone (BX): Nvidia Wants Wall Street to Lend Against AI Chips Like They’re Mortgages